" /> Mosaic variegated aneuploidy syndrome 1 - CISMeF





Preferred Label : Mosaic variegated aneuploidy syndrome 1;

Symbol : MVA1;

CISMeF acronym : MVA1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Mva syndrome;

Description : Mosaic variegated aneuploidy is an autosomal recessive disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues (Hanks et al., 2004). The proportion of aneuploid cells varies but is usually more than 25% and is substantially greater than in normal individuals. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor, and leukemia reported in several cases. See also MVA2 (614114), caused by mutation in the CEP57 gene (607951) on chromosome 11q21.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the BUB1 mitotic checkpoint serine/threonine kinase B gene (BUB1B, 602860.0003);

Neoplasia : Propensity to tumor development; Wilms tumor; Nephroblastoma; Rhabdomyosarcoma; Leukemia;

Laboratory abnormalities : Mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy; More than 50% of mitotic cells show premature chromatid separation (PCS) affecting all chromosomes; Anaphase loss or nondisjunction with trisomies, tetrasomies, monosomies;

Prefixed ID : #257300;

Details


You can consult :


Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.